BSPM (OTC)
BIOSTAR PHARMS INC
$0.000100
+0.000000 (+0.00%)
Prev close: $0.000100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Rong Hua Wang
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.00M
- Employees
- 200
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2010 (Q4)
|
$5.04 | $4.71 | +0.3276 | +6.95% |
Financial Statements
| Revenues | $317.79K |
| Cost Of Revenue | $354.54K |
| Gross Profit | -$36.75K |
| Nonoperating Income/Loss | $802.07K |
| Operating Expenses | -$2.82M |
| Depreciation and Amortization | $1.11M |
| Other Operating Expenses | -$5.08M |
| Operating Income/Loss | $2.79M |
| Income/Loss Before Equity Method Investments | $3.59M |
| Income/Loss From Continuing Operations After Tax | $934.35K |
| Income/Loss From Continuing Operations Before Tax | $3.59M |
| Income Tax Expense/Benefit | $2.65M |
| Interest Expense, Operating | $201.31K |
| Net Income/Loss | $934.35K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $934.35K |
| Net Income/Loss Available To Common Stockholders, Basic | $934.35K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.68 |
| Diluted Earnings Per Share | $0.68 |
| Basic Average Shares | 2,723,611 |
| Diluted Average Shares | 2,723,611 |
| Assets | $41.43M |
| Current Assets | $996.64K |
| Inventory | $170.56K |
| Prepaid Expenses | $80.00 |
| Other Current Assets | $826.00K |
| Noncurrent Assets | $40.43M |
| Fixed Assets | $5.85M |
| Intangible Assets | $5.38M |
| Other Non-current Assets | $29.20M |
| Liabilities | $5.28M |
| Current Liabilities | $5.28M |
| Noncurrent Liabilities | $0.00 |
| Equity | $36.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $36.15M |
| Liabilities And Equity | $41.43M |
| Net Cash Flow From Operating Activities | $8.59M |
| Net Cash Flow From Operating Activities, Continuing | $8.59M |
| Net Cash Flow From Investing Activities | -$10.78M |
| Net Cash Flow From Investing Activities, Continuing | -$10.78M |
| Net Cash Flow From Financing Activities | $1.71M |
| Net Cash Flow From Financing Activities, Continuing | $1.71M |
| Exchange Gains/Losses | $212.46K |
| Net Cash Flow | -$294.39K |
| Net Cash Flow, Continuing | -$506.85K |
| Comprehensive Income/Loss | $1.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.06M |
| Other Comprehensive Income/Loss | $1.06M |